Central regions | Finance, business

Russian biomed firm ready to sell antibodies to Europe

23 Jul '15
PrimeBioMed, an innovative Russian company, is ready to start exporting to the West its new antibodies to diagnose tumors, reported RVC, Russia’s fund of funds for innovation.

This has been made possible after this RVC portfolio company completed earlier this summer its ISO 13485 international standard certification procedure. The audit was conducted by Germany’s BSI Group Deutschland GmbH. PrimeBioMed’s certificate is valid for three years.

The company’s plans for later this year and next year include the commercialization of its products internationally. PrimeBioMed is reported to be currently in talks over partnerships with medical centers in Italy and Switzerland.

PrimeBioMed has been in Russia’s biomed business for less than a year.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Latest News: Central regions
16 Jan '18 | Finance, business | Technology & innovation
15 Jan '18 | Technology & innovation
11 Jan '18 | Finance, business | Technology & innovation
9 Jan '18 | Technology & innovation | Retail, FMCG
 

Feature stories

21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
Search (News archive - 21208)
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

19 Jan '18
Scientists in Samara have come up with a new method...
18 Jan '18
Scientists in St. Petersburg have partnered with...
17 Jan '18
Russian scientists in partnership with their Korean...

Most read stories from last week

16 Jan '18
Primer Capital, a Russian venture fund, has invested...
17 Jan '18
Russian scientists in partnership with their Korean...
18 Jan '18
Scientists in St. Petersburg have partnered with...